Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 - MUHC press release - September 2, 2020

Dr. Jean Bourbeau (Department of Epidemiology, Biostatistics and Occcupational Health Associate member) is the principal investigator on a clinical trial on a reformulated generic drug in COVID-19 positive outpatients.

Read the McGill University Health Centre press release

See also:

Un médicament générique contre la COVID-19 testé à Montréal - (article in French) La Presse, September 3, 2020

Un autre médicament contre la COVID-19 testé au Québec - (article in French) Journal de Montréal, September 3, 2020